ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE ON AGINGRF1

Prevalence, etiology, and clinical implications of low count monoclonal B-cell lymphocytosis (MBL)

Active
Institution
Mayo Clinic Rochester, MN
Principal investigator
Susan L Slager
Funding
$3.4M
Duration
2018–2029
Open portfolio

Moonbase score

Still being scored

Abstract

Monoclonal B-cell lymphocytosis (MBL) is one of the most common malignant precursor conditions, affecting 8-10 million adults >40 years of age in the United States. MBL is defined by the presence of a clonal B-cell population in the blood with sub-classification based on the immunophenotype of the cell surface markers and the size of the B-cell clone: low-count MBL (LCMBL) is defined as clonal B-cell count <0.5 x109 cells/L and high-count MBL (HCMBL) as clonal B-cell count between 0.5 and 5x109/L. Of clinical and

Research team

  • Tait D ShanafeltPI
  • Susan L SlagerPI

LOADING MOONBASE SCORE

RF1NATIONAL INSTITUTE ON AGINGCancer and Hematologic Disorders Study Section[CHD]clonalcountmonoclonalb-celladults yearsclonemblclinical implications

Questions for Mayo Clinic Rochester

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.